drugset / Trial / NCT05593653
Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia
RandomizedCrossoverQuadruple-blindTreatment
Summary
The aim of this study is to determine if suvorexant can help treat the severity of insomnia and improve metabolic health in midlife women who had both insomnia and indicators of metabolic syndrome.
Timeline
- Start
- 2023-01-06
- Primary completion
- 2025-10-24
- Completion
- 2025-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Suvorexant | Small molecule | 20 mg | Oral |